GO:0000722 telomere maintenance via recombination: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000722 (telomere maintenance via recombination) describes any recombinational process that contributes to the maintenance of proper telomeric length, and is also known as telomerase-independent telomere maintenance.
• Homologous recombination (HR) is the central molecular engine of this process, using RAD51-family recombinases and accessory factors to invade and copy telomeric DNA templates.
• The alternative lengthening of telomeres (ALT) pathway is the best-characterized manifestation of GO:0000722 in human cancer cells and depends on break-induced replication-like synthesis.
• Key genes include RAD51, RAD52, RAD54, BRCA1, BRCA2, MRE11, NBS1, RPA, POLD3, BLM, WRN, SIRT1, and TERRA-associated factors.
• GO:0000722 is studied in osteosarcoma, pancreatic neuroendocrine tumors, glioblastoma, and other ALT-positive cancers, and is a therapeutic target because ALT cells are hypersensitive to HR and replication-fork perturbations.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect which recombination factors are causally required for telomere maintenance.
Description
Telomeres are nucleoprotein structures that protect chromosome ends and shorten with each cell division in most somatic cells. When telomerase is absent or inhibited, a subset of cells maintains telomere length through recombination-based mechanisms collectively annotated as GO:0000722, telomere maintenance via recombination. This process is also called telomerase-independent telomere maintenance and is mechanistically distinct from canonical telomerase-mediated elongation. Understanding GO:0000722 matters because it underlies the alternative lengthening of telomeres (ALT) pathway, which sustains replicative immortality in a significant fraction of human cancers, including osteosarcoma and pancreatic neuroendocrine tumors. Because ALT cells depend on homologous recombination (HR) and replication-fork restart, they present unique vulnerabilities that can be exploited therapeutically. The process also intersects with nuclear architecture and long non-coding RNA biology, as TERRA transcripts and nuclear periphery factors modulate telomere recombination. This article synthesizes the QuickGO definition and verified PubMed literature to provide a research-grade overview of GO:0000722, its core genes, regulatory inputs, disease links, and the CRISPR-based methods used to study it.
telomere maintenance via recombination At A Glance
| GO ID | GO:0000722 |
|---|---|
| GO term | telomere maintenance via recombination |
| Ontology | biological_process |
| Synonym | telomerase-independent telomere maintenance |
| Definition | Any recombinational process that contributes to the maintenance of proper telomeric length. |
| Major function | Recombination-dependent elongation and stabilization of telomeric DNA when telomerase is absent or limiting. |
| Representative pathway | Alternative lengthening of telomeres (ALT) in human cancer cells. |
| Core molecular machinery | Homologous recombination factors including RAD51, RAD52, RAD54, BRCA1, BRCA2, MRE11, NBS1, RPA, and POLD3. |
| Model systems | Saccharomyces cerevisiae survivors, ALT-positive human cancer cell lines, and mouse xenografts. |
What Is GO:0000722?
GO:0000722 (telomere maintenance via recombination) is defined by QuickGO as any recombinational process that contributes to the maintenance of proper telomeric length. In practice, this encompasses homologous recombination (HR)-dependent mechanisms that use a telomeric or extrachromosomal template to elongate or stabilize chromosome ends independently of telomerase. The synonym telomerase-independent telomere maintenance emphasizes that this process operates when telomerase activity is low or absent, and it is frequently studied in ALT-positive cancer cells and in model organisms such as budding yeast survivors.
Why Is telomere maintenance via recombination Important in Cell Biology?
GO:0000722 is important because it provides a telomerase-independent route to telomere maintenance that supports unlimited proliferation in ALT cancers, and because the recombination factors that execute it are tractable therapeutic targets. In addition, the process is tightly linked to genome stability, nuclear organization, and long non-coding RNA regulation, making it a nexus for understanding how cells balance telomere protection with DNA repair.
• Provides a telomerase-independent mechanism for telomere elongation in ALT-positive cancers.
• Underlies replicative immortality in osteosarcoma and other ALT tumors.
• Requires homologous recombination factors such as RAD51, RAD52, and BRCA2.
• Is modulated by SIRT1, which contributes to telomere maintenance and augments global homologous recombination.
• Involves TERRA long non-coding RNAs and nuclear periphery factors that regulate telomere stability.
• Creates therapeutic vulnerabilities because ALT cells are hypersensitive to HR inhibition and replication stress.
• Is studied in human embryonic stem cells, where UBQLN1 links proteostasis and mitochondrial function to telomere maintenance.
• Can be modeled in yeast survivors to dissect recombination-based telomere maintenance genetically.
• Intersects with break-induced replication and POLD3-dependent DNA synthesis.
• Provides a paradigm for how recombination is targeted to specific chromosomal loci.
What Happens During telomere maintenance via recombination?
Initiation at critically short or damaged telomeres
In simple terms: When a telomere becomes too short or breaks, the cell treats it like a DNA damage site and starts recombination.
In GO:0000722, the process begins when telomeres lose their protective cap or become critically short, exposing a DNA end that is recognized by the MRE11-RAD50-NBS1 (MRN) complex and other damage sensors. Resection of the telomeric end generates 3' single-stranded DNA (ssDNA) overhangs, which are coated by replication protein A (RPA) and subsequently by RAD51 to form a nucleoprotein filament. This initiation step is a prerequisite for homology search and strand invasion, and it distinguishes recombination-based telomere maintenance from telomerase-mediated extension.
Homology search and strand invasion
In simple terms: The RAD51-coated DNA end searches for a matching telomere sequence and invades it to use as a template.
The RAD51-ssDNA filament performs homology search and strand invasion into a donor telomere or extrachromosomal telomeric repeat (ECTR) template. RAD54, a SWI2/SNF2-family translocase, stabilizes the filament and promotes synaptic complex formation, while BRCA2 mediates RAD51 loading onto ssDNA. In ALT cells, strand invasion can occur into sister telomeres, homologous chromosomes, or extrachromosomal telomeric circles, leading to template-dependent DNA synthesis.
Template-dependent DNA synthesis and telomere elongation
In simple terms: The invaded strand is extended by DNA polymerases using the donor telomere as a copy template.
Following strand invasion, a DNA polymerase extends the 3' end using the donor telomere as a template, a step analogous to break-induced replication (BIR). POLD3, a subunit of DNA polymerase delta, is required for this synthesis, and its stabilization by NPM1 phosphorylation supports telomere maintenance in ALT-positive osteosarcoma. The newly synthesized DNA is then processed, ligated, and resolved, resulting in net telomere elongation or telomere clustering that maintains telomere length homeostasis.
Resolution and telomere length homeostasis
In simple terms: After copying, the recombination intermediates are taken apart so the telomere can resume its protective role.
Recombination intermediates, including Holliday junctions and D-loops, are resolved by helicases and resolvases such as BLM and WRN, which are implicated in telomere maintenance and ALT suppression. SIRT1 contributes to telomere maintenance and augments global homologous recombination, linking NAD+-dependent deacetylation to recombination efficiency. TERRA transcripts and nuclear periphery factors further modulate resolution and telomere stability, ensuring that elongation is balanced with capping.
Telomere clustering and ALT-associated PML bodies
In simple terms: In ALT cells, telomeres gather into specialized nuclear compartments where recombination happens.
ALT-positive cells exhibit ALT-associated PML bodies (APBs) and telomere clustering, which concentrate recombination factors and telomeric DNA to facilitate GO:0000722. These structures are enriched in RAD51, RAD52, MRE11, and other HR proteins, and their formation correlates with active telomere elongation. Nuclear periphery and TERRA regulation influence the spatial organization of these events, linking nuclear architecture to recombination-based telomere maintenance.
Key Genes Involved in GO:0000722 telomere maintenance via recombination
The following genes and proteins are central to telomere maintenance via recombination (GO:0000722), based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAD51 | Forms nucleoprotein filament on ssDNA for homology search and strand invasion | Core HR recombinase; knockout is lethal and impairs ALT telomere maintenance |
| RAD52 | Mediates single-strand annealing and strand invasion; supports ALT | Loss reduces telomere recombination and ALT activity |
| RAD54 | SWI2/SNF2 translocase that stabilizes RAD51 filament | Required for efficient strand invasion at telomeres |
| BRCA1 | Promotes HR and telomere stability | Defects cause genome instability and altered telomere maintenance |
| BRCA2 | Loads RAD51 onto ssDNA | Essential for HR; loss impairs telomere recombination |
| MRE11 | Part of MRN complex; initiates end resection | Required for telomere recombination initiation |
| NBS1 | Part of MRN complex; recruits ATM to damage sites | Mutations cause Nijmegen breakage syndrome with telomere defects |
| RPA | Binds ssDNA and removes secondary structure | Facilitates RAD51 filament formation |
| POLD3 | DNA polymerase delta subunit for BIR-like synthesis | Stabilized by NPM1 phosphorylation in ALT osteosarcoma |
| NPM1 | Phosphorylation-mediated stabilization of POLD3 | Supports telomere maintenance in ALT-positive osteosarcoma |
| SIRT1 | NAD+-dependent deacetylase; augments HR | Contributes to telomere maintenance and global HR |
| BLM | RecQ helicase; resolves recombination intermediates | Loss causes Bloom syndrome and ALT-like phenotypes |
| WRN | RecQ helicase; maintains telomere stability | Defects cause Werner syndrome with telomere dysfunction |
| TERRA | Long non-coding RNA that regulates telomere stability | Modulates telomere recombination and ALT |
| UBQLN1 | Links proteostasis and mitochondrial function to telomere maintenance | Required for telomere maintenance in human embryonic stem cells |
| PML | Scaffolds ALT-associated PML bodies | Marks APBs in ALT cells |
| ATM | DNA damage kinase; coordinates HR at telomeres | Defects cause ataxia-telangiectasia with telomere abnormalities |
| ATRX | Chromatin remodeler; suppresses ALT | Loss is associated with ALT-positive cancers |
How Is telomere maintenance via recombination Regulated?
GO:0000722 is regulated at multiple levels. SIRT1 deacetylation activity contributes to telomere maintenance and augments global homologous recombination, linking metabolic NAD+ status to recombination efficiency. TERRA long non-coding RNAs regulate telomere stability and can modulate recombination at telomeres. NPM1 phosphorylation stabilizes POLD3 and supports telomere maintenance in ALT-positive osteosarcoma, providing a post-translational regulatory node. In addition, nuclear periphery factors and chromatin remodelers such as ATRX influence ALT activity and telomere recombination.
telomere maintenance via recombination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POLD3 | ALT-positive osteosarcoma | CRISPR knockout in U2OS or SAOS2 cells |
| NPM1 | ALT-positive osteosarcoma | Phospho-mutant knock-in in ALT cell lines |
| SIRT1 | Telomere maintenance and global HR | Overexpression and knockout in human fibroblasts |
| BLM | Bloom syndrome and ALT-like phenotypes | Knockout in HeLa or HEK293T cells |
| UBQLN1 | Human embryonic stem cell telomere maintenance | Knockout in H9 hESCs |
ALT-positive cancers
A significant subset of human cancers, including osteosarcoma and pancreatic neuroendocrine tumors, maintain telomeres through the ALT pathway, which is a manifestation of GO:0000722. ALT cells depend on homologous recombination and break-induced replication, and POLD3 stabilization by NPM1 phosphorylation is required for telomere maintenance in ALT-positive osteosarcoma. Because ALT cells are hypersensitive to HR inhibition and replication-fork perturbations, they present therapeutic opportunities.
Genome instability syndromes
Defects in recombination factors such as BLM, WRN, and MRN components cause Bloom syndrome, Werner syndrome, and Nijmegen breakage syndrome, respectively, all of which exhibit telomere dysfunction and genome instability. These syndromes highlight the importance of GO:0000722 in maintaining telomere integrity and preventing chromosomal aberrations.
Stem cell and developmental biology
In human embryonic stem cells, UBQLN1 links proteostasis and mitochondrial function to telomere maintenance, indicating that GO:0000722-related mechanisms operate in pluripotent cells. SIRT1 also contributes to telomere maintenance and global homologous recombination, linking metabolic regulation to telomere biology.
From telomere maintenance via recombination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is RAD51 required for ALT telomere maintenance? | CRISPR knockout of RAD51 in ALT-positive U2OS cells |
| Does NPM1 phosphorylation stabilize POLD3 at telomeres? | Point mutation of NPM1 phospho-sites in osteosarcoma cells |
| Can POLD3 knock-in rescue telomere maintenance? | Knock-in of POLD3 in POLD3-null ALT cells |
| Does SIRT1 overexpression enhance HR at telomeres? | Overexpression of SIRT1 in human fibroblasts |
| What is the role of TERRA in telomere recombination? | Knockout of TERRA loci or overexpression of TERRA in ALT cells |
| Is UBQLN1 required for telomere maintenance in hESCs? | Knockout of UBQLN1 in human embryonic stem cells |
How to Study the telomere maintenance via recombination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TRF analysis | Telomere length distribution | Detecting ALT activity in cancer cells |
| Q-FISH | Telomere length at single-cell level | Quantifying telomere elongation after gene knockout |
| C-circle assay | Extrachromosomal telomeric repeats | ALT biomarker in tumors |
| T-SCE | Telomere sister chromatid exchange | Measuring recombination at telomeres |
| CRISPR knockout | Loss-of-function phenotype | Testing requirement of RAD51, POLD3, or SIRT1 |
| CRISPR knock-in | Tagged or mutant protein expression | Tracking POLD3 at telomeres |
| Proteomics | Protein interactions at telomeres | Identifying recombination complexes |
| RNA-seq | Transcriptional changes | Measuring TERRA and HR gene expression |
Telomere length assays
Terminal restriction fragment (TRF) analysis, quantitative FISH (Q-FISH), and telomere repeat amplification protocol (TRAP) are used to measure telomere length and telomerase activity, distinguishing GO:0000722 from telomerase-dependent maintenance.
Recombination and ALT markers
ALT-associated PML bodies (APBs), C-circles, and telomere sister chromatid exchange (T-SCE) are markers of recombination-based telomere maintenance and are used to monitor GO:0000722 activity in cells.
CRISPR-based functional genomics
CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate genes in GO:0000722, as demonstrated for POLD3 and NPM1 in ALT osteosarcoma.
Proteomics and interactomics
Affinity purification and mass spectrometry identify recombination factor complexes at telomeres, including RAD51, MRE11, and POLD3, providing mechanistic insight into GO:0000722.
How CRISPR Can Be Used to Study GO:0000722 telomere maintenance via recombination
Knockout
CRISPR knockout of RAD51, RAD52, POLD3, or SIRT1 in ALT-positive cells can test whether these genes are required for telomere maintenance via recombination. Loss of POLD3 or NPM1 impairs telomere maintenance in osteosarcoma, demonstrating causality.
Point Mutation
Point mutations in NPM1 phosphorylation sites or in RAD51 catalytic residues can dissect post-translational regulation and catalytic requirements for GO:0000722.
Knock-in
Knock-in of tagged POLD3 or RAD51 allows live-cell imaging and chromatin immunoprecipitation to track recombination at telomeres.
Overexpression
Overexpression of SIRT1 or TERRA can enhance or perturb recombination-based telomere maintenance, revealing gain-of-function phenotypes.
How EDITGENE Supports telomere maintenance via recombination Research
Researchers studying telomere maintenance via recombination-related genes often need to determine whether a candidate gene is causally involved in telomere elongation, ALT activity, or recombination factor recruitment. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for GO:0000722 research.
Contact EDITGENE today to design your custom CRISPR model for telomere maintenance via recombination research.
Frequently Asked Questions About telomere maintenance via recombination
What is GO:0000722 telomere maintenance via recombination?
GO:0000722 is a Gene Ontology biological process defined as any recombinational process that contributes to the maintenance of proper telomeric length, also known as telomerase-independent telomere maintenance.
What genes are involved in telomere maintenance via recombination?
Key genes include RAD51, RAD52, RAD54, BRCA1, BRCA2, MRE11, NBS1, RPA, POLD3, NPM1, SIRT1, BLM, WRN, TERRA, and UBQLN1.
How is telomere maintenance via recombination different from telomerase?
Telomerase adds telomeric repeats using an RNA template, whereas GO:0000722 uses homologous recombination and DNA polymerases to copy telomeric sequences from a donor template.
What is the ALT pathway?
The alternative lengthening of telomeres (ALT) pathway is a recombination-based mechanism of telomere maintenance in cancer cells that is a manifestation of GO:0000722.
Which cancers use telomere maintenance via recombination?
ALT-positive cancers include osteosarcoma, pancreatic neuroendocrine tumors, and some glioblastomas.
What is the role of POLD3 in ALT?
POLD3, a DNA polymerase delta subunit, is required for break-induced replication-like synthesis during ALT telomere maintenance and is stabilized by NPM1 phosphorylation.
How does SIRT1 regulate telomere maintenance?
SIRT1 contributes to telomere maintenance and augments global homologous recombination, linking NAD+-dependent deacetylation to recombination efficiency.
What are ALT-associated PML bodies?
APBs are nuclear structures enriched in recombination factors and telomeric DNA that facilitate telomere clustering and recombination in ALT cells.
How can CRISPR be used to study GO:0000722?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes such as POLD3, NPM1, and SIRT1 in telomere maintenance.
What methods measure telomere maintenance via recombination?
TRF, Q-FISH, C-circle assay, T-SCE, and CRISPR-based functional genomics are commonly used to measure GO:0000722 activity.
Conclusion
GO:0000722 (telomere maintenance via recombination) is a biologically and clinically important process that enables telomerase-independent telomere elongation through homologous recombination. Its core machinery includes RAD51, RAD52, MRE11, BRCA1/2, POLD3, and SIRT1, and it is best characterized in ALT-positive cancers such as osteosarcoma. Understanding its regulation by NPM1 phosphorylation, TERRA, and nuclear periphery factors provides opportunities for therapeutic intervention. CRISPR-based models are indispensable for dissecting the causal roles of individual genes in this pathway.
References
- 1. San Filippo J et al.. 2008. Mechanism of eukaryotic homologous recombination.. Annu Rev Biochem 77:229-57 PMID: 18275380
- 2. Zhao R et al.. 2026. NPM1 phosphorylation-mediated telomere maintenance via stabilization of POLD3 in ALT-positive osteosarcoma: unraveling mechanisms and therapeutic opportunities.. Theranostics 16(8):4224-4244 PMID: 41695477
- 3. Juríková K et al.. 2021. Nuclear Periphery and Telomere Maintenance: TERRA Joins the Stage.. Trends Genet 37(7):608-611 PMID: 33663806
- 4. Palacios JA et al.. 2010. SIRT1 contributes to telomere maintenance and augments global homologous recombination.. J Cell Biol 191(7):1299-313 PMID: 21187328
- 5. Claussin C et al.. 2015. The many facets of homologous recombination at telomeres.. Microb Cell 2(9):308-321 PMID: 28357308
- 6. Muoio D et al.. 2025. The alternative lengthening of telomeres pathway through a DNA repair lens: mechanism and therapeutic opportunities.. NAR Cancer 7(4):zcaf056 PMID: 41480636
- 7. Zhao S et al.. 2024. UBQLN1 links proteostasis and mitochondria function to telomere maintenance in human embryonic stem cells.. Stem Cell Res Ther 15(1):180 PMID: 38902824
- 8. Rivosecchi J et al.. 2024. Telomere-specific regulation of TERRA and its impact on telomere stability.. Semin Cell Dev Biol 157:3-23 PMID: 38088000
